ICD-10-PCS Codes

• 1 3E0B304 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO EAR, PERCUTANEOUS APPROACH)

• 2 3E0B305 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO EAR, PERCUTANEOUS APPROACH)

• 3 3E0B30M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO EAR, PERCUTANEOUS APPROACH)

• 4 3E0B328 (INTRODUCTION OF OXAZOLIDINONES INTO EAR, PERCUTANEOUS APPROACH)

• 5 3E0B329 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO EAR, PERCUTANEOUS APPROACH)

• 6 3E0B33Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO EAR, PERCUTANEOUS APPROACH)

• 7 3E0B3BZ (INTRODUCTION OF ANESTHETIC AGENT INTO EAR, PERCUTANEOUS APPROACH)

• 8 3E0B3GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO EAR, PERCUTANEOUS APPROACH)

• 9 3E0B3HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO EAR, PERCUTANEOUS APPROACH)

• 10 3E0B3KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO EAR, PERCUTANEOUS APPROACH)

• 11 3E0B3NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO EAR, PERCUTANEOUS APPROACH)

• 12 3E0B3TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO EAR, PERCUTANEOUS APPROACH)

• 13 3E0B704 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 14 3E0B705 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 15 3E0B70M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 16 3E0B728 (INTRODUCTION OF OXAZOLIDINONES INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 17 3E0B729 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 18 3E0B73Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 19 3E0B7BZ (INTRODUCTION OF ANESTHETIC AGENT INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 20 3E0B7GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 21 3E0B7HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 22 3E0B7KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 23 3E0B7NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 24 3E0B7TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO EAR, VIA NATURAL OR ARTIFICIAL OPENING)

• 25 3E0BX04 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO EAR, EXTERNAL APPROACH)

• 26 3E0BX05 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO EAR, EXTERNAL APPROACH)

• 27 3E0BX0M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO EAR, EXTERNAL APPROACH)

• 28 3E0BX28 (INTRODUCTION OF OXAZOLIDINONES INTO EAR, EXTERNAL APPROACH)

• 29 3E0BX29 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO EAR, EXTERNAL APPROACH)

• 30 3E0BX3Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO EAR, EXTERNAL APPROACH)

• 31 3E0BXBZ (INTRODUCTION OF ANESTHETIC AGENT INTO EAR, EXTERNAL APPROACH)

• 32 3E0BXGC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO EAR, EXTERNAL APPROACH)

• 33 3E0BXHZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO EAR, EXTERNAL APPROACH)

• 34 3E0BXKZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO EAR, EXTERNAL APPROACH)

• 35 3E0BXNZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO EAR, EXTERNAL APPROACH)

• 36 3E0BXTZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO EAR, EXTERNAL APPROACH)